Literature DB >> 22122438

The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Mary E Ballestas1, Kenneth M Kaye.   

Abstract

Latency-associated nuclear antigen (LANA) is encoded by the Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) open reading frame 73. LANA is expressed during latent KSHV infection of cells, including tumor cells, such as primary effusion lymphoma, KS and multicentric Castleman's disease. Latently infected cells have multiple extrachromosomal copies of covalently closed circular KSHV genomes (episomes) that are stably maintained in proliferating cells. LANA's best characterized function is that of mediating episome persistence. It does so by binding terminal repeat sequences to the chromosomal matrix, thus ensuring episome replication with each cell division and efficient DNA segregation to daughter nuclei after mitosis. To achieve these functions, LANA associates with different host cell proteins, including chromatin-associated proteins and proteins involved in DNA replication. In addition to episome maintenance, LANA has transcriptional regulatory effects and affects cell growth. LANA exerts these functions through interactions with different cell proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122438      PMCID: PMC3857968          DOI: 10.2217/fmb.11.137

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  182 in total

1.  Interaction of the papillomavirus E2 protein with mitotic chromosomes.

Authors:  N Bastien; A A McBride
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus.

Authors:  E R Schultz; G W Rankin; M P Blanc; B W Raden; C C Tsai; T M Rose
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  A green fluorescent protein-reporter mammalian two-hybrid system with extrachromosomal maintenance of a prey expression plasmid: application to interaction screening.

Authors:  T Shioda; S Andriole; T Yahata; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

5.  Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.

Authors:  D R Schwam; R L Luciano; S S Mahajan; L Wong; A C Wilson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

7.  Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.

Authors:  P Norio; C L Schildkraut; J L Yates
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma.

Authors:  A Carbone; A M Cilia; A Gloghini; D Capello; L Fassone; T Perin; D Rossi; V Canzonieri; P De Paoli; E Vaccher; U Tirelli; R Volpe; G Gaidano
Journal:  Leukemia       Date:  2000-07       Impact factor: 11.528

9.  Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells.

Authors:  A Krithivas; D B Young; G Liao; D Greene; S D Hayward
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells.

Authors:  S A Radkov; P Kellam; C Boshoff
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

View more
  54 in total

1.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 2.  Touch, act and go: landing and operating on nucleosomes.

Authors:  Valentina Speranzini; Simona Pilotto; Titia K Sixma; Andrea Mattevi
Journal:  EMBO J       Date:  2016-01-19       Impact factor: 11.598

3.  Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.

Authors:  Theresa L Hodin; Tanbir Najrana; John L Yates
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

4.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.

Authors:  Xiaoxi Lin; Rui Sun; Fang Zhang; Yuan Gao; Lianghua Bin; Ke Lan
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

5.  The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.

Authors:  Jan Hellert; Magdalena Weidner-Glunde; Joern Krausze; Heinrich Lünsdorf; Christiane Ritter; Thomas F Schulz; Thorsten Lührs
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-06       Impact factor: 11.205

6.  Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA.

Authors:  Jin Gan; Chong Wang; Yanling Jin; Yi Guo; Feng Xu; Qing Zhu; Ling Ding; Hong Shang; Junwen Wang; Fang Wei; Qiliang Cai; Erle S Robertson
Journal:  Proteomics       Date:  2015-05-26       Impact factor: 3.984

7.  Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability.

Authors:  Jayaraju Dheekollu; Horng-Shen Chen; Kenneth M Kaye; Paul M Lieberman
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.

Authors:  Horng-Shen Chen; Priyankara Wikramasinghe; Louise Showe; Paul M Lieberman
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 9.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

10.  Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.

Authors:  Zhiguo Sun; Hem Chandra Jha; Erle S Robertson
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.